Colorectal Cancer Clinical Trials in Philadelphia, PA

Colorectal Cancer Clinical Trials in Philadelphia, PA

View the best 10 colorectal cancer medical studies in Philadelphia, Pennsylvania. Access promising new therapies by applying to a Philadelphia-based Colorectal Cancer clinical trial.

Trials in Philadelphia, Pennsylvania

Here are the top 10 medical studies for colorectal cancer in Philadelphia, Pennsylvania

Image of University of Southern California- Norris Cancer Center in Los Angeles, United States.

Decoy20

Decoy Receptor

Recruiting1 awardPhase 1 & 2
This trial studies a new drug to see if it's safe & effective against advanced solid tumors.
Image of MD Anderson in Houston, United States.

IDE-161

PARP Inhibitor

Recruiting1 awardPhase 1
This trial is testing a new drug called IDE161 to see if it is safe and effective for patients with advanced cancers that have specific genetic changes. The drug works by preventing cancer cells from repairing their DNA, which can lead to their death.
Image of Research Site in Duarte, United States.

AZD9592

Recruiting1 awardPhase 1
This trial is testing a new drug called AZD9592 in patients with advanced solid tumors. The goal is to see if AZD9592 can help treat these cancers, either on its own or with other treatments. Researchers are looking at how safe the drug is, how well patients tolerate it, and if it can shrink or stop the growth of tumors.
Image of Alaska Oncology in Anchorage, United States.

Capecitabine +3 More

Anti-metabolites

Recruiting1 awardPhase 1 & 2
This trial studies a combo therapy for colorectal cancer, to see if it's safe and effective.
Image of M D Anderson Cancer Center in Houston, United States.

Cemiplimab

Checkpoint Inhibitor

Recruiting1 awardPhase 2
This trial will test if cemiplimab can help people with dMMR colon cancer manage their disease.
Image of GSK Investigational Site in Tucson, United States.

Dostarlimab +2 More

PD-1 Inhibitor

Recruiting2 awardsPhase 3
This trial is testing dostarlimab, a drug that helps the immune system fight cancer. It targets patients with a specific type of colon cancer that has certain genetic features and can be surgically removed. Dostarlimab works by helping the immune system recognize and destroy cancer cells.
Image of USC Norris Comprehensive Cancer Center in Los Angeles, United States.

HFB200603 +1 More

Chemotherapy

Recruiting1 awardPhase 1
This trial tests the safety and effectiveness of two cancer treatments, HFB200603 and tislelizumab, in patients with advanced cancers.
Image of SCRI Oncology Partners in Nashville, United States.

Zanidatamab

Monoclonal Antibodies

Recruiting1 awardPhase 2
This trial is testing a new drug called zanidatamab to see how well it works and if it is safe for treating people with certain types of solid tumors that have a specific protein called
Image of UC Irvine Health/Chao Family Comprehensive Cancer Center in Orange, United States.

Capecitabine

Recruiting2 awardsPhase 3
This trial aims to determine if giving chemotherapy alone before limited surgery is as effective as giving chemotherapy and radiation therapy together before surgery in treating rectal cancer. It also seeks to understand if quality of life is
Image of HonorHealth Research Institute in Scottsdale, United States.

Balstilimab +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 2
This trial tests botensilimab alone or with balstilimab in adults with advanced colorectal cancer who didn't respond to previous chemotherapy. The new drugs aim to enhance the immune system's ability to fight cancer.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.